Preferred Label : epidermal growth factor;
MeSH definition : A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands.
Human epidermal growth factor was originally isolated from urine based on its ability
to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts
a wide variety of biological effects including the promotion of proliferation and
differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane
protein which can be cleaved to release a soluble active form.;
MeSH synonym : egf; epidermal growth factor-urogastrone; growth factor, epidermal; growth factor-urogastrone, epidermal; human urinary gastric inhibitor; urogastrone; beta urogastrone; beta-Urogastrone;
CISMeF synonym : growth factors, epidermal;
MeSH CAS label : epidermal growth factor;
Registry Number MeSH : 62229-50-9;
Wikipedia link : https://en.wikipedia.org/wiki/Epidermal growth factor;
Codes EINECS : 263-468-7;
Is substance : O;
Origin ID : D004815;
UMLS CUI : C0242275;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
- E 6010 [MeSH Supplementary Concept]
- E1-INT [MeSH Supplementary Concept]
See also
Semantic type(s)
UMLS correspondences (same concept)
A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands.
Human epidermal growth factor was originally isolated from urine based on its ability
to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts
a wide variety of biological effects including the promotion of proliferation and
differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane
protein which can be cleaved to release a soluble active form.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015140.pub2/full/fr
2025
United Kingdom
review of literature
french abstract
EGF Receptors
mutation
epidermal growth factor-urogastrone receptor site
due to
adjuvant, nos
neoplasm, malignant
epidermal growth factor
neoplasm staging
persons
carcinoma, non-small-cell lung
disease
"u" lymphocyte
small cell lung carcinoma
excision, nos
receptors, growth factor
tyrosine
receptor Protein-Tyrosine kinases
Tyrosine Kinase Inhibitors
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-en-contexte-quebecois-des-inhibiteurs-de-la-tyrosine-kinase-du-recepteur-du-facteur-de-croissance-epidermique-egfr-pour-le-traitement-du-cancer-du-poumon.html
2022
Canada
technical report
Lung cancer
tyrosine
tyrosine
EGF Receptors
receptors, growth factor
epidermal growth factor-urogastrone receptor site
lung neoplasms
receptor Protein-Tyrosine kinases
epidermal growth factor
lung cancer
neoplasm, malignant
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/4A/6A/resume.phtml?type=text.html
2009
France
French
journal article
Tyrosine Kinase Inhibitors
carcinoma, hepatocellular
epidermal growth factor
receptors, vascular endothelial growth factor
vascular endothelial growth factor a
carcinoma, hepatocellular
antibodies, monoclonal
ErbB Receptors
---